MedTrace Logo

Clinical Trial of Integrated Treatment for Pain and Opioid Dependence

NCT00634803 · Status: COMPLETED · Phase: PHASE1/PHASE2 · Type: INTERVENTIONAL · Enrollment: 90

Last updated 2021-08-02

Study results available
· View outcomes & findings →

Summary

This study is designed to develop an effective psychotherapy for chronic pain and opioid dependence.

Conditions

Interventions

BEHAVIORAL

CBT

Cognitive behavioral therapy

DRUG

Buprenorphine

buprenorphine/naloxone

OTHER

Educational Counseling

Didactic, lecture-discussion format to supplement information and advice provided by physicians

OTHER

Physician Management

Brief physician counseling

Sponsors & Collaborators

  • National Institute on Drug Abuse (NIDA)

    collaborator NIH

  • Yale University

    lead OTHER

Principal Investigators

  • Richard S Schottenfeld, MD · Yale University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-09-30
Primary Completion
2015-05-31
Completion
2015-08-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00634803 on ClinicalTrials.gov